Shin Poong has established a number of overseas branches.
SHINPOONG PHARM.CO.,LTD.

R&D

Pipeline

  • HOME
  • R&D
  • Pipeline
Preclinical Phase 1 Phase 2 Phase 3/4 Marketed
Cardiovascular disease

SP-8257

Stroke, Atherosclerosis

SP-8356

Stroke, Atherosclerosis

Otaplimastat
(SP-8203)

Aute ischemic stroke

CandeAmlo®

Hypertension

CandeAmlo plus™

Hypertension

EzeRosu®

Hyperlipidemia
Musculoskeletal Disorders

SP-LI-N1

Sarcopenia

Joint Steering

Hyaltop®

Osteoarthritis

Hyalflex®

Osteoarthritis
Medical Device

Medicurtain Plus

Anti-adhesion
+anti-inflammatory

Medicurtain®

Anti-adhesion
Infectious disease

Pyramax® tablets

COVID-19

Drug repurposing

Pyramax® tablets

Malaria

WHO-MMV

Pyramax® granules

Malaria

WHO-MMV
Platform technology

Fomulation Technology

Controlled release, GRDDS, Double layer formulation, Tablet in Capsule, etc.

Long-acting nucleotide/peptide

Research on months-long sustained effects of siRNA/peptide